CAREDX, INC. Net Income (Loss) Available to Common Stockholders, Diluted
CAREDX, INC. (CDNA) reported Net Income (Loss) Available to Common Stockholders, Diluted of $110.64 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2026-07-30
- CAREDX, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2026-06-30 was $110.64M.
- CAREDX, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2026-03-31 was $2.81M.
- CAREDX, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2025-12-31 was -$4.11M, a 104.68% decline year-over-year.
- CAREDX, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2025-09-30 was $1.68M.
- CAREDX, INC. net income (loss) available to common stockholders, diluted for fiscal 2025 was -$21.35M, a 140.64% decline from fiscal 2024.
- CAREDX, INC. net income (loss) available to common stockholders, diluted for fiscal 2024 was $52.55M.
- CAREDX, INC. net income (loss) available to common stockholders, diluted for fiscal 2023 was -$190.28M.
- CAREDX, INC. net income (loss) available to common stockholders, diluted for fiscal 2022 was -$76.61M.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month as first filed | Net Income (Loss) Available to Common Stockholders, Diluted 9 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month as first filed | Net Income (Loss) Available to Common Stockholders, Diluted 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $110.64M 10-Q · filed 2026-07-30 | $113.44M 10-Q · filed 2026-07-30 | $109.34M derived: sum of 3 quarters · filed 2026-07-30 | $111.01M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2026-03-31 | $2.81M 10-Q · filed 2026-04-28 | -$1.30M derived: sum of 2 quarters · filed 2026-04-28 | $376.00K derived: sum of 3 quarters · filed 2026-04-28 | -$8.19M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-12-31 | -$4.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$2.43M derived: sum of 2 quarters · filed 2026-02-25 | -$11.00M derived: sum of 3 quarters · filed 2026-07-30 | -$21.35M 10-K · filed 2026-02-25 | |||
| 2025-09-30 | $1.68M 10-Q · filed 2025-11-04 | -$6.89M derived: sum of 2 quarters · filed 2026-07-30 | -$17.25M 10-Q · filed 2025-11-04 | $70.45M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-06-30 | -$8.57M 10-Q · filed 2026-07-30 | -$18.92M 10-Q · filed 2026-07-30 | $68.78M derived: sum of 3 quarters · filed 2026-07-30 | $58.14M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-03-31 | -$10.35M 10-Q · filed 2026-04-28 | $77.34M derived: sum of 2 quarters · filed 2026-04-28 | $66.71M derived: sum of 3 quarters · filed 2026-04-28 | $62.08M derived: sum of 4 quarters · filed 2026-04-28 | |||
| 2024-12-31 | $87.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $77.06M derived: sum of 2 quarters · filed 2026-02-25 | $72.44M derived: sum of 3 quarters · filed 2026-02-25 | $52.55M 10-K · filed 2026-02-25 | |||
| 2024-09-30 | -$10.64M 10-Q · filed 2025-11-04 | -$7.41M 10-Q · filed 2024-11-04 | -$15.26M derived: sum of 2 quarters · filed 2025-11-04 | -$35.15M 10-Q · filed 2025-11-04 | -$25.46M 10-Q · filed 2024-11-04 | -$153.25M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-06-30 | -$4.62M 10-Q · filed 2025-08-06 | -$1.39M 10-Q · filed 2024-07-31 | -$24.51M 10-Q · filed 2025-08-06 | -$18.05M 10-Q · filed 2024-07-31 | -$142.61M derived: sum of 3 quarters · filed 2026-02-25 | -$166.09M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-03-31 | -$19.89M 10-Q · filed 2025-04-30 | -$16.66M 10-Q · filed 2024-05-09 | -$137.99M derived: sum of 2 quarters · filed 2026-02-25 | -$161.47M derived: sum of 3 quarters · filed 2026-02-25 | -$186.42M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2023-12-31 | -$118.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$141.58M derived: sum of 2 quarters · filed 2026-02-25 | -$166.53M derived: sum of 3 quarters · filed 2026-02-25 | -$190.28M 10-K · filed 2026-02-25 | |||
| 2023-09-30 | -$23.48M 10-Q · filed 2024-11-04 | -$48.44M derived: sum of 2 quarters · filed 2024-11-04 | -$72.19M 10-Q · filed 2024-11-04 | -$90.52M derived: sum of 4 quarters · filed 2025-02-28 | |||
| 2023-06-30 | -$24.95M 10-Q · filed 2024-07-31 | -$48.70M 10-Q · filed 2024-07-31 | -$67.03M derived: sum of 3 quarters · filed 2025-02-28 | -$83.97M derived: sum of 4 quarters · filed 2025-02-28 | |||
| 2023-03-31 | -$23.75M 10-Q · filed 2024-05-09 | -$42.08M derived: sum of 2 quarters · filed 2025-02-28 | -$59.02M derived: sum of 3 quarters · filed 2025-02-28 | -$80.71M derived: sum of 4 quarters · filed 2025-02-28 | |||
| 2022-12-31 | -$18.33M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$35.27M derived: sum of 2 quarters · filed 2025-02-28 | -$56.97M derived: sum of 3 quarters · filed 2025-02-28 | -$76.61M 10-K · filed 2025-02-28 | |||
| 2022-09-30 | -$16.94M 10-Q · filed 2023-11-08 | -$38.64M derived: sum of 2 quarters · filed 2023-11-08 | -$58.28M 10-Q · filed 2023-11-08 | -$74.44M derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2022-06-30 | -$21.70M 10-Q · filed 2023-08-08 | -$41.34M 10-Q · filed 2023-08-08 | -$57.50M derived: sum of 3 quarters · filed 2024-02-28 | -$69.39M derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2022-03-31 | -$19.65M 10-Q · filed 2023-05-10 | -$35.80M derived: sum of 2 quarters · filed 2024-02-28 | -$47.70M derived: sum of 3 quarters · filed 2024-02-28 | -$49.62M derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2021-12-31 | -$16.15M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$28.05M derived: sum of 2 quarters · filed 2024-02-28 | -$29.98M derived: sum of 3 quarters · filed 2024-02-28 | -$30.66M 10-K · filed 2024-02-28 | |||
| 2021-09-30 | -$11.90M 10-Q · filed 2022-11-03 | -$13.82M derived: sum of 2 quarters · filed 2022-11-03 | -$14.51M 10-Q · filed 2022-11-03 | ||||
| 2021-06-30 | -$1.93M 10-Q · filed 2022-08-04 | -$2.61M 10-Q · filed 2022-08-04 | |||||
| 2021-03-31 | -$687.00K 10-Q · filed 2022-05-05 | ||||||
| 2020-12-31 | -$18.71M 10-K · filed 2023-02-27 | ||||||
| 2019-12-31 | -$21.97M 10-K · filed 2022-02-24 | ||||||
| 2018-12-31 | -$46.76M 10-K · filed 2021-02-24 | ||||||
| 2017-12-31 | -$31.67M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | -$45.94M derived: sum of 2 quarters · filed 2020-02-28 | -$49.91M derived: sum of 3 quarters · filed 2020-02-28 | -$55.47M 10-K · filed 2020-02-28 | |||
| 2017-09-30 | -$14.27M 10-Q · filed 2017-11-09 | -$18.24M derived: sum of 2 quarters · filed 2017-11-09 | -$23.80M 10-Q · filed 2017-11-09 | -$39.28M derived: sum of 4 quarters · filed 2019-03-06 | |||
| 2017-06-30 | -$3.97M 10-Q · filed 2017-08-11 | -$9.53M 10-Q · filed 2017-08-11 | -$25.01M derived: sum of 3 quarters · filed 2019-03-06 | -$30.16M derived: sum of 4 quarters · filed 2019-03-06 | |||
| 2017-03-31 | -$5.56M 10-Q · filed 2017-06-09 | -$21.04M derived: sum of 2 quarters · filed 2019-03-06 | -$26.19M derived: sum of 3 quarters · filed 2019-03-06 | -$36.66M derived: sum of 4 quarters · filed 2019-03-06 | |||
| 2016-12-31 | -$15.48M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | -$20.63M derived: sum of 2 quarters · filed 2019-03-06 | -$31.10M derived: sum of 3 quarters · filed 2019-03-06 | -$39.47M 10-K · filed 2019-03-06 | |||
| 2016-09-30 | -$5.15M 10-Q · filed 2017-11-09 | -$15.62M derived: sum of 2 quarters · filed 2017-11-09 | -$23.99M 10-Q · filed 2017-11-09 | -$30.13M derived: sum of 4 quarters · filed 2018-03-22 | |||
| 2016-06-30 | -$10.47M 10-Q · filed 2017-08-11 | -$20.22M 10-Q · filed 2017-08-11 | -$24.98M derived: sum of 3 quarters · filed 2018-03-22 | -$28.47M derived: sum of 4 quarters · filed 2018-03-22 | |||
| 2016-03-31 | -$9.75M 10-Q · filed 2017-06-09 | -$14.51M derived: sum of 2 quarters · filed 2018-03-22 | -$18.00M derived: sum of 3 quarters · filed 2018-03-22 | -$21.19M derived: sum of 4 quarters · filed 2018-03-22 | |||
| 2015-12-31 | -$4.76M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | -$8.25M derived: sum of 2 quarters · filed 2018-03-22 | -$11.44M derived: sum of 3 quarters · filed 2018-03-22 | -$13.71M 10-K · filed 2018-03-22 | |||
| 2015-09-30 | -$3.49M 10-Q · filed 2016-11-14 | -$6.67M derived: sum of 2 quarters · filed 2016-11-14 | -$8.95M 10-Q · filed 2016-11-14 | ||||
| 2015-06-30 | -$3.19M 10-Q · filed 2015-08-12 | -$5.46M 10-Q · filed 2015-08-12 | |||||
| 2014-12-31 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-21 | $1.32M derived: sum of 2 quarters · filed 2017-04-21 | $2.21M derived: sum of 3 quarters · filed 2017-04-21 | $907.00K 10-K · filed 2017-04-21 | |||
| 2014-09-30 | $1.32M 10-Q · filed 2015-11-13 | $2.22M derived: sum of 2 quarters · filed 2015-11-13 | $912.00K 10-Q · filed 2015-11-13 | ||||
| 2014-06-30 | $892.00K 10-Q · filed 2015-08-12 | -$427.00K 10-Q · filed 2015-08-12 | |||||
| 2013-12-31 | -$562.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | -$1.39M derived: sum of 2 quarters · filed 2016-03-29 | -$2.19M derived: sum of 3 quarters · filed 2016-03-29 | -$3.54M 10-K · filed 2016-03-29 | |||
| 2013-09-30 | -$830.00K 10-Q · filed 2014-11-14 | -$1.63M derived: sum of 2 quarters · filed 2014-11-14 | -$2.98M 10-Q · filed 2014-11-14 | ||||
| 2013-06-30 | -$802.00K 10-Q · filed 2014-08-28 | -$2.15M 10-Q · filed 2014-08-28 | |||||
| 2012-12-31 | -$5.06M 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |